Bigul

APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) for the period ended 30th June 2021 is enclosed
05-07-2021
Bigul

APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Statement Of Investor Complaints For The Quarter Ended June 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 014140 Name of the Signatory :- S M KRISHNANDesignation :- Company Secretary and Compliance Officer
03-07-2021
Bigul

APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Dear Sir, Sub: Intimation in terms of Regulation 39(3) of the SEBI (LODR) Regulations, 2015 (Regulations) regarding loss of share certificate. This is to inform you that the Company has received intimation from shareholders on July 3, 2021 regarding loss of share certificates. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificates are as given below: Folio No. Name of the Shareholder(s) No of equity shares held Share Certificate No. Distinctive Nos. 1243 Blaze Kannan 1000 351243 4001359 to 4002358 This is for your information.
03-07-2021
Bigul

APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Shareholding for the Period Ended June 30, 2021

Apollo Hospitals Enterprise Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here
03-07-2021

Apollo hospitals to hold nationwide Covid vaccination drive on Wednesday

A leading hospital group on Tuesday announced that it will conduct a pan-India Covid vaccination drive on June 30 spanning 50 cities, to boost the national inoculation exercise.
29-06-2021

Buy Apollo Hospitals; target of Rs 3870: ICICI Direct

ICICI Direct is Apollo Hospitals recommended buy rating on the stock with a target price of Rs 3870 in its research report dated June 25, 2021.
28-06-2021
Next Page
Close

Let's Open Free Demat Account